Blood Product Inventory Research Articles

Reducing blood product wastage through the inter-hospital redistribution of near-outdate inventory.

Hospital transfusion services order blood products to satisfy orders and maintain inventory levels during unexpected periods of increased blood demand. Surplus inventory may outdate before being allocated to a recipient. Blood product outdating is the largest contributor to blood wastage. A province-wide redistribution program was designed and implemented to redistribute near-outdate plasma protein and related blood products from low-usage to high-usage hospitals. Program operations and details are described in this paper. Two transport container configurations were designed and validated for transport of all blood products. A cost-analysis was performed to determine the effectiveness of this redistribution program. A total of 130 hospital transfusion services contributed at least one near-outdate blood product for redistribution between January 2012 and March 2020. These services redistributed 15,499 products through 3412 shipments, preventing the outdating of $17,570,700 CAD worth of product. Program costs were $14,900 for shipping and $30,000 for staffing. Failed time limits or non-compliance with packing configurations resulted in $388,200 worth of blood products (97 shipments containing 816 products) being discarded. Courier transport delays was the most common reason (42/97; 43%) for transport failure. Redistributing near-outdate blood products between hospitals is a feasible solution to minimize outdating. Despite heterogeneity of Canadian blood product inventory, all products (each with unique storage and transport requirements) were successfully redistributed in one of two validated and simple containers. Total operation costs of this program were small in comparison to the $17.6 million in savings associated with preventing the discard of outdated products.

Simulation- optimisation approach to support management of blood components inventory

ABSTRACT Blood supply chains (BSCs) face challenges in managing the production and inventory of blood components. We developed a simulation-optimisation approach to address inventory of blood products in blood supply chains. This approach can determine inventory size and replenishment points for blood products that balances supply and demand, while maintaining acceptable levels of wastage and shortage. A simulation methodology is used to represent the complexities in the inventory management of blood components. An optimisation module, coupled with the simulation, is used to address constraints related to waste, shortages, and inventory levels. The approach was verified and validated using a case study conducted in a blood bank in Brazil managing a supply of Red Blood Cells (RBCs). The approach proved to be suitable for the case analyzed and results suggest that 120 units is adequate to meet the demand for RBCs, while maintaining acceptable levels of shortages and wastages.

Recent trends in perioperative blood transfusion during elective kidney transplantation.

Accurately predicting the demand for blood transfusions is crucial for blood banks. Given the potential for emergency situations, it is imperative that blood banks maintain a sufficient inventory of blood products. In this study, we examined the use of perioperative transfusions in patients undergoing elective kidney transplants. Data on all complement-dependent cytotoxicity-crossmatched assays between 2013 and 2022 were collected. We excluded repeated assays and patients who did not undergo kidney transplantation. Transfusion records and transfusion adverse reactions were reviewed retrospectively. In total, 30 patients underwent elective kidney transplantation from 2013 to 2022. The mean age of the patients was 48.1±9.7 years. The male-to-female ratio was 1.5:1. Four patients received transfusions intraoperatively, whereas eight patients were transfused postoperatively. The postoperative hemoglobin level of the transfusion group (n=9, 8.9±1.3) was significantly lower than that of the nontransfusion group (n=21, 10.4±1.2). The most commonly transfused blood product intraoperatively was leuko-reduced filtered red blood cells, followed by fresh frozen plasma. When the study period was divided into two halves based on the time of operation, the first half showed a higher number of significant transfusions. In most elective kidney transplant cases, surgery was conducted without the need for blood transfusion. The timing of transfusion, when necessary, shifted from during the operation to after the operation. The implementation of patient blood management, coupled with advancements in surgical techniques, appears to have impacted the pattern of perioperative transfusion.

Using Interactive Visual Analytics to Optimize Blood Products Inventory at a Blood Bank.

Blood products and their derivatives are perishable commodities that require an efficient inventory management to ensure both a low wastage rate and a high product availability rate. To optimize blood product inventory, Blood Transfusion Services (BTS) need to reduce wastage by avoiding outdates and improving availability of different blood products. We took a blood product lifecycle approach and used advanced visualization techniques to design and develop a highly interactive web-based dashboard to audit retrospective data and consequently, to identify and learn from procedural inefficiencies based on analysis of transactional data. We present pertinent scenarios to show how the blood transfusion staff can use the dashboard to investigate blood product lifecycles so as to probe transition sequence patterns that led to wastage as a means to discover causes of procedural inefficiencies in the BTS.

Using Interactive Visual Analytics to Optimize in Real-Time Blood Products Inventory at a Blood Bank.

Blood products and their derivatives are perishable commodities that require an efficient inventory management to ensure both a low wastage rate and a high product availability rate. To optimize blood product inventory, blood transfusion services need to reduce wastage by avoiding outdates and improve availability of different blood products. We used advance visualization techniques to design and develop a highly interactive real-time web-based dashboard to monitor the blood product inventory and the on-going blood unit transactions in near-real-time based on analysis of transactional data. Blood transfusion staff use the dashboard to locate units with specific characteristics, investigate the lifecycle of the units, and efficiently transfer units between facilities to minimize outdates.

Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve.

BackgroundBlood suppliers and transfusion services have worked diligently to maintain an adequate blood supply during the COVID‐19 pandemic. Our experience has shown that some COVID‐19 inpatients require transfusion support; understanding this need is critical to blood product inventory management.Study Design and MethodsHospital‐wide and COVID‐19 specific inpatient blood product utilization data were collected retrospectively for our networkʼs two tertiary academic medical centers over a 9‐week period (March 1, 2020‐May 2, 2020), when most inpatients had COVID‐19. Utilization data were merged with a COVID‐19 patient database to investigate clinical demographic characteristics of transfused COVID‐19 inpatients relative to non‐transfused ones.ResultsOverall, 11 041 COVID‐19 patients were admitted and 364 received blood product transfusions for an overall transfusion rate of 3.3%. COVID‐19 patients received 1746 blood components in total, the majority of which were red blood cells. COVID‐19 patientsʼ weekly transfusion rate increased as the pandemic progressed, possibly reflecting their increased severity of illness. Transfusion was significantly associated with several indicators of severe disease, including mortality, intubation, thrombosis, longer hospital admission, lower hemoglobin and platelet nadirs, and longer prothrombin and activated partial thromboplastin times. As the pandemic progressed, institutional adherence to transfusion guidelines improved for RBC transfusions compared to prior year trends but did not improve for platelets or plasma.ConclusionThere is a need to closely monitor the blood product inventory and demand throughout the COVID‐19 pandemic as patientsʼ transfusion needs may increase over time. Daily or weekly trending of patientsʼ clinical status and laboratory values may assist blood banks in inventory management.

Transfusion Thresholds for Adult Respiratory Extracorporeal Life Support: An Expert Consensus Document

Severe acute respiratory distress syndrome (ARDS) can complicate novel pandemic coronavirus disease (COVID-19). Extracorporeal life support (ECLS) represents the final possible rescue strategy. Variations in practice, combined with a paucity of rigourous guidelines, may complicate blood-product resource availability and allocation during a pandemic. We conducted a literature review around venovenous extracorporeal membrane oxygenation (VV-ECMO) transfusion practices for platelets, packed red blood cells, fresh frozen plasma, prothrombin complex concentrate, and antithrombin. Pertinent society guidelines were examined, and the practice of Canadian ECLS experts was sampled through an environmental scan. This paper represents a synthesis of these explorations, combined with input from the Canadian Cardiovascular Critical Care (CANCARE) Society, Canadian Society of Cardiac Surgeons, and the Canadian Critical Care Society. We offer a pragmatic guidance document for restrictive transfusion thresholds in nonbleeding patients on VV-ECMO, which may attenuate transfusion-related complications and simultaneously shield national blood product inventory from strain during pandemic-induced activation of the National Plan for the Management of Shortages of Labile Blood Components.

REDUCING WASTAGES AND SHORTAGES OF BLOOD PRODUCTS AT HOSPITALS WITH CONSIDERING ABO/RH(D) COMPATIBILITY

Blood supply chain management is one of the main components of a healthcare system of each country. This chain is comprised of two significant components including collecting donators’ blood and supplying blood’s products. We present a novel constrained mathematical model for a two-echelon blood supply chain network to minimize both wasted cost and lack of inventory of blood products in hospitals. Some techniques are used to linearize the model’s nonlinear terms and decrease presented model’s complexity. The model is implemented on Tabriz’s blood supply chain network with multiple supply points and 44 hospitals. The model is solved on GAMS software under 5 different scenarios and 18 time periods. Computational results showed that hospitals are tended in accepting products’ holding and waste costs to satisfy demands of patients who are in critical need for receiving blood products. Due to the compatibility of different groups of blood, the cost of supplying the red blood cells (RBCs) has decreased by 18% and the inventory of o + blood group has decreased to adapt to other groups of blood.

Development and Implementation of Real-Time Web-Based Dashboards in a Multisite Transfusion Service

Background: In hospital transfusion services, visualization of blood product inventory in the form of web-based dashboards has the potential to improve the workflow and efficiency of blood product inventory management. While off-the-shelf “business intelligence” solutions by external vendors may offer the ability to display and analyze blood bank inventory data, laboratories may lack resources to readily access this technology. Using in-house talent, our transfusion service developed real-time, web-based dashboards to replace manual processes for managing both blood product inventory and cooler tracking at two large academic hospital blood banks. Methods: Dashboards were developed using Hypertext Markup Language, Cascading Style Sheets, and Hypertext Preprocessor scripting/programming languages. Data are extracted in real time from Sunquest (v7.3) Laboratory Information Systems Database (InterSystems Cache) and are refreshed every 2 min. Data are hosted internally by our institution’s web servers and are accessed on a webpage via Microsoft Group Policy shortcuts. Results: Dashboards were designed and implemented to provide a fully customizable, dynamic, and secure method of displaying blood product inventory and blood product cooler status. Transfusion service staff utilized dashboard data to maintain adequate blood product supply, modify blood product replacement orders to prevent excess inventory, and transfer short-dated blood products between our facilities to minimize wastage. Conclusions: Dashboard technology can be readily implemented at hospital transfusion services with minimal capital expenditure. The implementation of real-time web-based dashboards for blood product inventory and cooler management at our centers facilitated on-demand blood product monitoring and replaced a tedious, manual process with a user-friendly and intuitive electronic tool.

Contingency planning for natural disasters

Contingency planning for natural disasters

Scientific aspects of supplying blood to distant military theaters

Reduction in combat zone morbidity and mortality requires rapid delivery of safe blood products as an integral element of advanced trauma surgical care. This review of the current literature presents scientific aspects of supplying blood for rapid delivery to enhance survival and patient outcome in the combat zone. Most deaths due to hemorrhage can be averted by transfusion during the first hour from injury; therefore, maintaining a dependable inventory of blood products in combat support hospitals is essential. Current casualty care in distant geographic locations involves rapid air evacuation to combat support hospitals or fleet hospitals, where massive transfusions may be required. Resuscitation by forward surgical teams utilizing red blood cells before air evacuation or in-flight has also been reported. To improve survival, these massive transfusions should be composed of not only red blood cells but also other blood components and plasma factors. Rapid on-site combat casualty transfusion support requires specialized blood transport containers and transfusion practices not observed in noncombat settings, such as the mobile walking blood bank and a frozen blood program. Additionally, technology for improved transport containers, cell-free hemoglobin-based oxygen carriers, freeze-dried blood, and recombinant activated coagulation factor has attracted focused interest.